Product NDC: | 76282-202 |
Proprietary Name: | Fosinopril sodium |
Non Proprietary Name: | Fosinopril sodium |
Active Ingredient(s): | 40 mg/1 & nbsp; Fosinopril sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 76282-202 |
Labeler Name: | Exelan Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077222 |
Marketing Category: | ANDA |
Start Marketing Date: | 20050621 |
Package NDC: | 76282-202-90 |
Package Description: | 90 TABLET in 1 BOTTLE (76282-202-90) |
NDC Code | 76282-202-90 |
Proprietary Name | Fosinopril sodium |
Package Description | 90 TABLET in 1 BOTTLE (76282-202-90) |
Product NDC | 76282-202 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fosinopril sodium |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20050621 |
Marketing Category Name | ANDA |
Labeler Name | Exelan Pharmaceuticals, Inc. |
Substance Name | FOSINOPRIL SODIUM |
Strength Number | 40 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |